17-69254325-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_172232.4(ABCA5):āc.4234G>Cā(p.Val1412Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,604,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_172232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA5 | NM_172232.4 | c.4234G>C | p.Val1412Leu | missense_variant | 32/39 | ENST00000392676.8 | NP_758424.1 | |
ABCA5 | NM_018672.5 | c.4234G>C | p.Val1412Leu | missense_variant | 31/38 | NP_061142.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA5 | ENST00000392676.8 | c.4234G>C | p.Val1412Leu | missense_variant | 32/39 | 1 | NM_172232.4 | ENSP00000376443 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000163 AC: 4AN: 245772Hom.: 0 AF XY: 0.00000753 AC XY: 1AN XY: 132818
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1452142Hom.: 0 Cov.: 31 AF XY: 0.0000111 AC XY: 8AN XY: 721754
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | The c.4234G>C (p.V1412L) alteration is located in exon 31 (coding exon 31) of the ABCA5 gene. This alteration results from a G to C substitution at nucleotide position 4234, causing the valine (V) at amino acid position 1412 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at